Joint Corticosteroid Injection Linked to Increased Risk for Influenza
Joint corticosteroid injections may decrease influenza vaccine efficacy.
Joint corticosteroid injections may decrease influenza vaccine efficacy.
Seven studies were included in a meta-analysis examining the potential benefit of bisphosphonate therapy in knee osteoarthritis.
Insulin resistance may be experienced by patients with T2D who receive an intra-articulate corticosteroid of betamethasone injection at the knee joint.
Seventy-five randomized controlled trials were included in a meta-analysis comparing DDP-4 inhibitors with placebo and other diabetes medications.
A prospective, observational study sought to evaluate and characterize the nature of rheumatic disorders associated with immune checkpoint inhibitors.
Short-acting opioids are comparable with long-acting opioid medications for managing pain in patients with chronic osteoarthritis.
Bisphosphonates did not show to be beneficial for patients with knee osteoarthritis.
Investigators randomly assigned DMARD-naive patients were randomly assigned to tocilizumab, step-up methotrexate or a combination of both medications.
TNFi persistence and factors influencing persistence were investigated in patients who were treated with TNFi therapy for the first time.
Data from 6 cohorts were used to evaluate and establish the relationship between multibiomarker disease activity score and radiographic progression risk.